Table 1.
Clinical characteristics of patients.
| Characteristics | CTR | D | DME |
|---|---|---|---|
| Demographic, n = | 10 | 8 | 12 |
| Age, mean (SD; range), years | 71 (4.8; 65–78) | 72 (5,1; 65–78) | 69 (4.9; 57–79) |
| Sex, No. (%) | |||
| Male | 7 (70%) | 6 (75%) | 8 (67%) |
| Female | 3 (30%) | 2 (33%) | 4 (33%) |
| BMI, mean (SD; range) | 25 (3.2; 22–33) | 28 (2.6, 26–34) | 27 (1.8; 23–30) |
| Comorbidities, No. (%) | |||
| No comorbidities | 2 (20%) | - | - |
| HTN | 4 (40%) | 8 (100%) | 12 (100%) |
| BPH | 2 (20%) | 3 (37%) | - |
| MI | 1 (10%) | - | 2 (17%) |
| DLP | 2 (20%) | 2 (25%) | 3 (25%) |
| Others | 2 (20%) | 2 (25%) | 2 (17%) |
| Treatment, No. (%) | |||
| Metformin | - | 5 (62%) | 5 (42%) |
| Insulin | - | 2 (25%) | 7 (58%) |
| Other diabetic drugs | - | 3 (37%) | 3 (25%) |
| HTN drugs | 5 (50%) | 7 (87%) | 11 (92%) |
| Antiplatelet drugs | 1 (10%) | 3 (37%) | 3 (25%) |
| BPH drugs | 2 (20%) | 2 (25%) | - |
| DLP drugs | 2 (20%) | 2 (25%) | 3 (25%) |
| Others | 2 (20%) | 3 (37%) | 3 (25%) |
| Laterality, No. (%) | |||
| Right | 4 (40%) | 4 (50%) | 5 (42%) |
| Left | 6 (60%) | 4 (50%) | 7 (58%) |
| Best-corrected Visual Acuity | |||
| Snellen, mean (range) | 20/40 (20/25–20/50) | 20/40 (20/32–20/63) | 20/40 (20/25–20/100) |
| LogMAR, mean (SD; range) | 0.3 (0.1; 0.1–0.4) | 0.3 (0.1; 0.2–0.5) | 0.3 (0.2; 0.1–0.7) |
| OCT Features | |||
| Central subfield thickness, mean (SD; range), µm |
272.4 (12.3; 251–289) | 275 (8.2; 263–289) | 447.7 (86.6; 319–604) |
| Grading of Diabetic Retinopathy, No. (%) | |||
| Mild | Not applicable | absent | 6 |
| Moderate | Not applicable | absent | 6 |
| Severe | Not applicable | absent | absent |
| Duration of diabetes, mean (SD; range), years |
Not applicable | 7 (1.5; 5–10) | 6 (2.7; 1–11) |
| HbA1c, mean (SD; range) | Not applicable | 7 (0.3; 6.9–7.8) | 8.0 (1.23; 6.6–10.2) |
CTR: patients without diabetes; D: patients with type 2 diabetes without diabetic macular edema; DME: patients with type 2 diabetes with diabetic macular edema; HTN: hypertension; BPH: Benign prostatic hyperplasia; MI: myocardial infarction; DLP: Dyslipidemia.